Company Description
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.
The company was founded in 1998 and is based in Beijing, China.
Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.
| Country | CN |
| IPO Date | n/a |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Jianfei Zhang |
Contact Details
Address: NET Building Beijing, CN | |
| Website | https://www.ftzy.com.cn |
Stock Details
| Ticker Symbol | PTHL |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001970544 |
| CUSIP Number | n/a |
| ISIN Number | KYG713991027 |
| Employer ID | 00-0000000 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jianfei Zhang | Chief Executive Officer & Chairman of the Board |
| Zhixin Li | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 15, 2024 | 6-K | Filing |
| Sep 09, 2024 | 6-K | Filing |
| Sep 06, 2024 | 424B4 | Filing |
| Sep 03, 2024 | CERT | Filing |
| Mar 26, 2024 | CORRESP | Filing |
| Mar 26, 2024 | CORRESP | Filing |
| Dec 22, 2023 | CORRESP | Filing |
| Dec 19, 2023 | UPLOAD | Filing |
| Dec 08, 2023 | CORRESP | Filing |
| Dec 01, 2023 | UPLOAD | Filing |